Autonomix Medical, Inc. (AMIX)

3.92 -0.15 (-3.69%) USD  |  NASDAQ  |  Sep 25, 16:00
3.95 +0.03 (+0.77%) After-Hours: 19:59
More

Autonomix Medical Research and Development Expense (Annual) : 7.144M for March 31, 2026

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for AMIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2022. Start Trial.
Date Value
March 31, 2026 7.144M
March 31, 2025 4.725M
March 31, 2024 2.225M
Date Value
March 31, 2023 0.6572M
March 31, 2022 0.0041M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Abbott Laboratories 2.889B
AngioDynamics, Inc. 29.45M
Alphatec Holdings, Inc. 76.27M
AtriCure, Inc. 90.17M
Baxter International, Inc. 503.00M